Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)

Detalhes bibliográficos
Autor(a) principal: European Antimicrobial Resistance Surveillance Network (EARS-Net)
Data de Publicação: 2014
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.18/2958
Resumo: Portugal - EARS-Net Management Team & National representatives of EARS-Net (Manuela Caniça, José Artur Paiva, Vera Manageiro, Eugénia Ferreira)
id RCAP_8b4be005a5e71af723908adb59fab09f
oai_identifier_str oai:repositorio.insa.pt:10400.18/2958
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)Resistência aos AntibióticosEARS-NetAntimicrobial ResistanceEuropePortugalPortugal - EARS-Net Management Team & National representatives of EARS-Net (Manuela Caniça, José Artur Paiva, Vera Manageiro, Eugénia Ferreira)The results presented in this report are based on antimicrobial resistance data from invasive isolates reported to EARS-Net by 30 EU/EEA countries in 2014 (data referring to 2013), and on trend analyses of EARS-Net data reported by the participating countries during the period 2010 to 2013. The antimicrobial resistance situation in Europe displays large variations depending on bacteria, antimicrobial group and geographical region. For several antimicrobial group and bacterium combinations, a north-to-south and west-to-east gradient is evident in Europe. In general, lower resistance percentages are reported by countries in the north and higher percentages reported by countries in the south and east of Europe. Overall, the most concerning trends in Europe in 2013 were related to the occurrence of resistance in gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter species). For E. coli and K. pneumoniae, a continuous increase in resistance to key antimicrobial groups was noted. A majority of the isolates reported to EARS-Net in 2013 was resistant to at least one of the antimicrobial groups under surveillance, and many of these showed combined resistance to third-generation cephalosporins, fluoroquinolones and aminoglycosides. Over the last four years (2010 to 2013), resistance to third-generation cephalosporins in K. pneumoniae and E. coli increased significantly at EU/EEA level, as well as in many of the individual Members States. Many of the isolates resistant to third-generation cephalosporins were ESBL-positive and showed resistance to additional antimicrobial groups. In addition, resistance to fluoroquinolones, aminoglycosides and carbapenems, as well as combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides increased significantly at EU/EEA level for K. pneumoniae, but not for E. coli. Interestingly, there was a decrease in fluoroquinolone resistance in P. aeruginosa, which was seen for both the EU/EEA population-weighted mean percentage as well as in the trends for several individual countries, whereas fluoroquinolone resistance increased in K. pneumoniae. While the EU/EEA population-weighted mean for carbapenem resistance was 8.3% for K. pneumoniae, carbapenem resistance remained very low in E. coli (0.2%). However, five countries reported trends of increasing carbapenem resistance in E. coli in 2013; four of them belonging to the countries with the highest levels of resistance. Carbapenem resistance and resistance to multiple antimicrobial groups were also common in Pseudomonas aeruginosa and Acinetobacter spp. isolates. Data for polymyxin resistance (colistin and polymyxin B) were limited but indicated the presence of polymyxin resistance in all gram-negative bacterial species included in EARS-Net reporting, especially in countries with already high levels of carbapenem resistance. Resistance trends for gram-positive bacteria showed a more diverse pattern across Europe. For meticillin-resistance in Staphylococcus aureus (MRSA), the population-weighted EU/EEA mean has decreased significantly over the last four years. The decrease has, however, been less pronounced compared with the previous four-year period. The trends for Streptococcus pneumoniae were generally stable, but with large inter-country variations in the percentage of resistant isolates. Macrolide non-susceptibility in S. pneumoniae was, for most countries, higher than the percentages for penicillin-non-susceptibility. For enterococci, the population-weighted EU/EEA mean percentage for vancomycin resistance in E. faecium increased significantly between 2010 and 2013. The decrease in the percentage of high-level aminoglycoside resistant E. faecalis observed in a number of countries in recent years continued in 2013, although the populationweighted EU/EEA mean showed no significant change.European Centre for Disease Prevention and Control (ECDC)Repositório Científico do Instituto Nacional de SaúdeEuropean Antimicrobial Resistance Surveillance Network (EARS-Net)2015-02-25T17:14:44Z20142014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reportapplication/pdfhttp://hdl.handle.net/10400.18/2958eng978-92-9193-603-82363-266610.2900/39777info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:39:32Zoai:repositorio.insa.pt:10400.18/2958Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:37:54.740323Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
title Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
spellingShingle Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
European Antimicrobial Resistance Surveillance Network (EARS-Net)
Resistência aos Antibióticos
EARS-Net
Antimicrobial Resistance
Europe
Portugal
title_short Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
title_full Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
title_fullStr Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
title_full_unstemmed Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
title_sort Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
author European Antimicrobial Resistance Surveillance Network (EARS-Net)
author_facet European Antimicrobial Resistance Surveillance Network (EARS-Net)
author_role author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv European Antimicrobial Resistance Surveillance Network (EARS-Net)
dc.subject.por.fl_str_mv Resistência aos Antibióticos
EARS-Net
Antimicrobial Resistance
Europe
Portugal
topic Resistência aos Antibióticos
EARS-Net
Antimicrobial Resistance
Europe
Portugal
description Portugal - EARS-Net Management Team & National representatives of EARS-Net (Manuela Caniça, José Artur Paiva, Vera Manageiro, Eugénia Ferreira)
publishDate 2014
dc.date.none.fl_str_mv 2014
2014-01-01T00:00:00Z
2015-02-25T17:14:44Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/2958
url http://hdl.handle.net/10400.18/2958
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 978-92-9193-603-8
2363-2666
10.2900/39777
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv European Centre for Disease Prevention and Control (ECDC)
publisher.none.fl_str_mv European Centre for Disease Prevention and Control (ECDC)
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132114585649152

Registros relacionados